There is no consensus from published reports with regard to changes in the expression of OCTN2 in cancer (Calcagno et al., 2006; Fujiya et al., 2011; Martini et al., 2012; Scalise et al., 2012). The gene discussed is SLC22A5; the disease is cancer.